Sponsored by Biolab Holdings

Speaker: Dr. Windy Cole

Traditional randomized controlled trials remain the gold standard for establishing treatment efficacy, yet their restrictive eligibility criteria, high costs, and limited generalizability often fail to reflect the complexity of real-world wound care populations. 

Using the CAMP RWE study as a case example, the session will highlight the integration of prospective clinical data, registry-based matched controls, patient-reported outcomes, and pragmatic enrollment strategies to generate rigorous, practice-relevant evidence.  The evolving acceptance of RWE by the FDA and CMS and its implications for future wound care innovation, product evaluation, and coverage policy will also be discussed. 

Speakers to be announced soon!

As reimbursement policies continue to evolve, understanding the Physician Fee Schedule is essential for providers delivering care in post-acute settings. This session will examine the latest updates, identify which services and providers stand to benefit or face new challenges, and explore the potential impact of wound care practices.

Martha Kelso

Delivering wound care in the mobile setting requires both strong clinical assessment skills and the effective use of portable technologies. This session will explore approaches to differential diagnosis, as well as the tools and equipment available to support wound assessment, treatment, monitoring, and care planning in the field. Attendees will gain practical insights into leveraging mobile technologies—from vascular assessment devices and imaging tools to documentation and communication platforms—to enhance clinical decision-making and improve patient outcomes across diverse care environments.

Take the opportunity to network with colleagues, connect with industry partners, and explore the latest products, technologies, and innovations in wound care.

Speaker TBC

Session description TBC

Dr. James Kramer

Drawing from more than two years of clinical experience using MolecuLight, Dr. James Kramer will share how Moleculight has become an essential tool in his mobile wound care practice. Through practical workflow examples and real-world patient cases, he will discuss how Moleculight helps uncover hidden bacterial burden, supports earlier intervention, and targeted treatment decisions to achieve better wound healing outcomes. 

William O’Malley

Session description TBC

Navigating the Complexities of Lower
Extremity Wounds with UltraMIST

Dr. Shishir Shah and Dr. William Tettelbach

Take the opportunity to network with colleagues, connect with industry partners, and explore the latest products, technologies, and innovations in wound care.

Dr. Thomas Serena, Dr. Gregory Bohn, Ryan Dirks, Dr. Daniel Kapp, Bill O’Malley

Navigating reimbursement challenges and clawbacks can be one of the most complex aspects of wound care. In this expert panel, seasoned clinicians with firsthand experience in audits and Administrative Law Judge (ALJ) hearings will share practical lessons learned. Attendees will gain insight into common pitfalls, effective defense strategies, and best practices to protect reimbursement while maintaining compliance in an increasingly scrutinized environment.

Ryan Dirks

Preventing pressure injuries starts with mastering the fundamentals. This session will allow attendees to gain practical, evidence-based strategies to reduce incidence, improve patient outcomes, and reinforce a culture of proactive care across settings.

Martha Kelso

Navigating consolidated billing requirements can be challenging for wound care providers. This session will provide a practical overview of consolidated billing rules, common reimbursement pitfalls, and their impact on wound care services, products, and procedures. Attendees will gain insights to help improve compliance, avoid denied claims, and support appropriate reimbursement for the care they provide.

Zweli Tunyiswa

Rural America represents a significant and underserved opportunity in wound care, with 22% of adults over age 65—nearly 12 million people—living in rural communities. Combined with over $150 billion in government investment aimed at improving rural health access, the market is primed for innovation and growth. This session will highlight the unique challenges and emerging opportunities in rural wound care, and how providers can expand services to meet growing demand while improving outcomes for this vulnerable population.

Take the opportunity to network with colleagues, connect with industry partners, and explore the latest products, technologies, and innovations in wound care.

Zweli Tunyiswa

Dedicated wound care specialists play a critical role in improving quality measures within nursing homes. This session will examine how specialized expertise drives better clinical outcomes, reduces pressure injuries, supports regulatory compliance, and enhances overall facility performance. Attendees will learn how integrating wound care specialists into care teams can elevate standards, improve survey readiness, and deliver measurable value in long-term care settings.

Dr. Daniel Kapp

Legal concerns and audit risk often deter providers from engaging in mobile wound care, but strong documentation can turn uncertainty into confidence. This session will explore how clear, compliant, and thorough documentation practices not only support high-quality patient care but also reduce legal exposure and audit anxiety. Attendees will gain practical insights into documentation strategies that meet regulatory standards and protect providers.

Dr. Kashif Saeed

Post-acute wound-care practices operate across fragmented facilities, clinical systems, documentation requirements, and reimbursement models. Emerging technologies, including artificial intelligence, have the potential to reduce this fragmentation, but their value depends on how effectively they support the complete patient encounter.

Drawing on more than a decade of experience as both a practicing post-acute physician and healthcare technology builder, Dr. Kashif Saeed will examine how technology is evolving across four critical areas of practice performance: encounter preparation, intelligent clinical documentation, revenue integrity, and operational intelligence.

Using practical examples, the session will explore where technology and AI are meaningfully improving provider efficiency, documentation quality, clinical and financial alignment, and organizational visibility—as well as where technology has created new complexity or failed to deliver on its promise.

Attendees will leave with a practical framework for evaluating emerging technology and preparing their organizations for the next generation of post-acute wound care.

Amanda Fuller

Dr. Amber Poirot

Nancy Morgan

Compression therapy remains the cornerstone of venous leg ulcer management, yet advances in products, techniques, and patient-centred care continue to shape clinical practice. This session will explore modern compression strategies, review the latest evidence, and provide practical guidance on selecting and applying compression therapies to improve healing outcomes, enhance patient adherence, and reduce recurrence.

Take the opportunity to network with colleagues, connect with industry partners, and explore the latest products, technologies, and innovations in wound care.

Dr. William Tettelbach

Hard-to-heal wounds are associated with significant morbidity, mortality, and healthcare costs, yet regulatory frameworks often classify the wound separately from its downstream complications. This session will examine emerging evidence demonstrating that the persistent open wound itself is the driving source of infection, sepsis, amputation, and death. Attendees will explore the implications of current FDA and payer policies on innovation, access to advanced therapies, and patient outcomes, while considering whether hard-to-heal wounds should be recognized as life-threatening conditions requiring a different regulatory approach.

Dr. Marcus Gitterle

Calciphylaxis is a rare but devastating condition associated with extremely high mortality, often presenting as painful skin lesions and rapidly progressing ulcers. In this session, Dr Marcus Gitterle will review the latest understanding of calciphylaxis pathophysiology, key clinical features, diagnostic challenges, and emerging treatment strategies. The presentation will explore the role of vitamin K deficiency, current evidence for vitamin K supplementation, the limitations of traditional therapies such as sodium thiosulfate, and best practices in wound management. Attendees will gain practical insights to support earlier recognition and more effective management of this complex and life-threatening disease.

Dr. Jeffrey Niezgoda

Ultrasound therapy has become an increasingly valuable adjunct in wound management, offering clinicians additional options to promote healing in complex and non-healing wounds. This session will compare contact and non-contact ultrasound technologies, reviewing their mechanisms of action, clinical applications, advantages, limitations, and current evidence base. Attendees will gain practical guidance on patient selection, treatment considerations, and how to incorporate ultrasound therapy into a comprehensive wound care plan to help optimize healing outcomes.

Speaker: Amanda Fuller

Copper dressings are increasingly being used as part of advanced wound care strategies due to their broad-spectrum antimicrobial properties and potential to support the wound healing environment. In this session, Amanda Fuller will share real-world experience of incorporating copper dressings into clinical practice across a range of wound types. Attendees will explore the rationale for copper-based technologies, patient and wound selection considerations, practical application techniques, and observed clinical outcomes.

Take the opportunity to network with colleagues, connect with industry partners, and explore the latest products, technologies, and innovations in wound care.

SmartTRAK

Dr. Mark Suski

As antimicrobial resistance continues to pose a global healthcare challenge, responsible antimicrobial use is more important than ever in wound care. This session will explore the principles of antimicrobial stewardship, discuss appropriate product selection and prescribing practices, and provide practical strategies for balancing effective infection management with the need to preserve antimicrobial efficacy for the future.

Dr. Marcus Gitterle

Diabetic foot ulcers are a leading cause of lower-extremity amputation, but many amputations can be prevented through timely, evidence-based care. In this session, Dr. Marcus Gitterle will discuss common causes of DFU treatment failure, including missed vascular disease, inadequate offloading, infection management challenges, and gaps in coordinated care. Attendees will gain practical strategies for improving healing outcomes, reducing amputation risk, and building effective limb preservation programs in both community and specialty care settings

Dr. Jeffrey Niezgoda

Optimal wound healing begins with effective wound bed preparation. This session will explore evidence-based strategies for assessing and optimizing the wound environment, including debridement, moisture balance, bioburden management, edema control, and addressing underlying barriers to healing. Attendees will gain practical insights into applying current best practices to promote granulation tissue formation, support advanced therapies, and improve outcomes for patients with chronic and complex wounds.

Matthew Davis

Choosing the right patient and preparing the wound environment appropriately are critical steps in the effective use of CAMPs. Attendees will leave with actionable strategies to improve patient outcomes and enhance confidence in clinical decision-making surrounding CAMPs therapies.

Take the opportunity to network with colleagues, connect with industry partners, and explore the latest products, technologies, and innovations in wound care.

Bjorn Sprengers

Cold plasma technology is emerging as one of the most promising innovations in advanced wound care. Following a growing body of evidence and increasing clinical adoption across Europe, leading cold plasma companies are now preparing to enter the U.S. market. What makes this technology so promising? How does it work, what does the clinical evidence show, and where could it fit in the future standard of care for complex wounds? Join this session to explore the science, the evidence, and the opportunities that could make cold plasma a transformative force in U.S. wound care.

Dr. Jordan Meyers

This session presents interim results from the STABLECAMP trial evaluating cellular, acellular, and matrix‑like products (CAMPs) for chronic lower extremity ulcers. Using Bayesian hierarchical modeling, the analysis demonstrates higher estimated 12‑week closure rates with dual‑ and four‑layer amniotic membrane allografts compared with standard of care alone in both DFUs and VLUs.

Zweli Tunyiswa

Subramanian Gunasekaran / Moderator: Murugan Gunasekaran

This presentation, “Enhancing Skin Substitute Performance with Type-I Collagen,” presents the scientific and clinical rationale for using high-purity, native, uncross-linked Type-I collagen as an advanced regenerative biomaterial, highlighting how collagen purity, nativity, fibrillar structure, porosity, and biochemical modification through phosphorylation can enhance cellular interactions, vascularization, and tissue regeneration. Using Helicoll® as the clinical example, it reviews randomized clinical evidence in diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs), including comparisons with amniotic-derived matrices, and emphasizes the potential of phosphorylated, purified Type-I collagen to function as a biologically interactive regenerative matrix rather than merely a wound covering or dressing